Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 36

Cited In for PubMed (Select 17058219)

1.

Clinicopathological subclassification of biliary cystic tumors: Report of 4 cases with a review of the literature.

Yamashita S, Tanaka N, Takahashi M, Hata S, Nomura Y, Ooe K, Suzuki Y.

Intractable Rare Dis Res. 2013 May;2(2):63-8. doi: 10.5582/irdr.2013.v2.2.63.

2.

An intraductal papillary neoplasm of the bile duct at the duodenal papilla.

Kawaguchi Y, Kawashima Y, Maruno A, Ito H, Ogawa M, Izumi H, Furukawa D, Yazawa N, Nakagori T, Hirabayashi K, Mine T.

Case Rep Oncol. 2014 Jul 2;7(2):417-21. doi: 10.1159/000364999. eCollection 2014 May.

3.

Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)".

Nakanuma Y, Sato Y, Ojima H, Kanai Y, Aishima S, Yamamoto M, Ariizumi S, Furukawa T, Hayashi H, Unno M, Ohta T; Hepatolithiasis Subdivision of Intractable Hepatobiliary Diseases Study Group of Japan (Chairman, Hirohito Tsubouchi).

Int J Clin Exp Pathol. 2014 May 15;7(6):3112-22. eCollection 2014.

4.

Intraductal papillary neoplasms of the bile duct.

Ohtsuka M, Shimizu H, Kato A, Yoshitomi H, Furukawa K, Tsuyuguchi T, Sakai Y, Yokosuka O, Miyazaki M.

Int J Hepatol. 2014;2014:459091. doi: 10.1155/2014/459091. Epub 2014 May 18. Review.

5.

The outcome of ipsilateral hemihepatectomy in mucin-producing bile duct tumors.

Yang XW, Yang J, Li L, Yan XZ, Zhang BH, Shen F, Wu MC.

PLoS One. 2014 Apr 11;9(4):e92010. doi: 10.1371/journal.pone.0092010. eCollection 2014.

6.

Magnetic resonance evaluations of biliary malignancy and condition at high-risk for biliary malignancy: Current status.

Sugita R.

World J Hepatol. 2013 Dec 27;5(12):654-65. doi: 10.4254/wjh.v5.i12.654. Review.

7.

Intraductal papillary neoplasm of the bile duct.

Wan XS, Xu YY, Qian JY, Yang XB, Wang AQ, He L, Zhao HT, Sang XT.

World J Gastroenterol. 2013 Dec 14;19(46):8595-604. doi: 10.3748/wjg.v19.i46.8595. Review.

8.

Intraductal papillary mucinous neoplasm of the pancreas: an update.

Xiao SY.

Scientifica (Cairo). 2012;2012:893632. doi: 10.6064/2012/893632. Epub 2012 Nov 28. Review.

9.

Metachronous intracystic and intraductal papillary neoplasms of the biliary tree.

Sato H, Sato Y, Harada K, Sasaki M, Hirano K, Nakanuma Y.

World J Gastroenterol. 2013 Sep 28;19(36):6125-6. doi: 10.3748/wjg.v19.i36.6125.

10.

Participation of peribiliary glands in biliary tract pathophysiologies.

Igarashi S, Sato Y, Ren XS, Harada K, Sasaki M, Nakanuma Y.

World J Hepatol. 2013 Aug 27;5(8):425-32. doi: 10.4254/wjh.v5.i8.425.

11.

Pathological aspects of so called "hilar cholangiocarcinoma".

Castellano-Megías VM, Ibarrola-de Andrés C, Colina-Ruizdelgado F.

World J Gastrointest Oncol. 2013 Jul 15;5(7):159-70. doi: 10.4251/wjgo.v5.i7.159.

12.

An intraductal papillary neoplasm of the bile duct mimicking a hemorrhagic hepatic cyst: a case report.

Kakisaka T, Kamiyama T, Yokoo H, Nakanishi K, Wakayama K, Tsuruga Y, Kamachi H, Mitsuhashi T, Taketomi A.

World J Surg Oncol. 2013 May 24;11:111. doi: 10.1186/1477-7819-11-111.

13.
14.

Expression of keratin 20 and its clinicopathological significance in intrahepatic cholangiocarcinoma.

Choi JE, Noh SJ, Lee JH, Bae JS, Chu HH, Park HS, Jang KY, Chung MJ, Kang MJ, Lee DG, Moon WS.

Oncol Lett. 2012 Sep;4(3):534-540. Epub 2012 Jun 13.

15.

GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct.

Matthaei H, Wu J, Dal Molin M, Debeljak M, Lingohr P, Katabi N, Klimstra DS, Adsay NV, Eshleman JR, Schulick RD, Kinzler KW, Vogelstein B, Hruban RH, Maitra A.

HPB (Oxford). 2012 Oct;14(10):677-83. doi: 10.1111/j.1477-2574.2012.00504.x. Epub 2012 Jun 18.

16.

Intraductal neoplasm of the intrahepatic bile duct: clinicopathological study of 24 cases.

Naito Y, Kusano H, Nakashima O, Sadashima E, Hattori S, Taira T, Kawahara A, Okabe Y, Shimamatsu K, Taguchi J, Momosaki S, Irie K, Yamaguchi R, Yokomizo H, Nagamine M, Fukuda S, Sugiyama S, Nishida N, Higaki K, Yoshitomi M, Yasunaga M, Okuda K, Kinoshita H, Nakayama M, Yasumoto M, Akiba J, Kage M, Yano H.

World J Gastroenterol. 2012 Jul 28;18(28):3673-80. doi: 10.3748/wjg.v18.i28.3673.

17.

Simultaneous intraductal papillary neoplasms of the bile duct and pancreas treated with chemoradiotherapy.

Valente R, Capurso G, Pierantognetti P, Iannicelli E, Piciucchi M, Romiti A, Mercantini P, Larghi A, Federici GF, Barucca V, Osti MF, Di Giulio E, Ziparo V, Delle Fave G.

World J Gastrointest Oncol. 2012 Feb 15;4(2):22-5. doi: 10.4251/wjgo.v4.i2.22.

18.

Malignant intraductal oncocytic papillary neoplasm of the common bile duct.

Terada T.

Int J Clin Exp Pathol. 2012;5(1):96-101. Epub 2012 Jan 9.

19.

Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma.

O'Dell MR, Huang JL, Whitney-Miller CL, Deshpande V, Rothberg P, Grose V, Rossi RM, Zhu AX, Land H, Bardeesy N, Hezel AF.

Cancer Res. 2012 Mar 15;72(6):1557-67. doi: 10.1158/0008-5472.CAN-11-3596. Epub 2012 Jan 20.

20.

Tutorial review for understanding of cholangiopathy.

Nakanuma Y.

Int J Hepatol. 2012;2012:547840. doi: 10.1155/2012/547840. Epub 2011 Aug 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk